Evidence map›Paper›PMID 32591864›Full record

ArticleParasitology research2020

Diagnostic value of glycoprotein band patterns of three serologic enzyme-linked immunoelectrotransfer blot assays for neurocysticercosis.

Matthew L Romo, Marisela Hernández, Osvaldo-Germán Astudillo, Gustavo Diego, Jorge Luis de-la-Rosa-Arana, Antonio Meza-Lucas, Ricardo García-Rodea, Andrea Toledo, R Michael E Parkhouse, Teresa Garate and 2 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Parasitology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Rapid Detection ofFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 6 countries.

Matthew L RomoCUNY Graduate School of Public Health and Health Policy and Institute for Implementation Science in Population Health, City University of New York, New York, NY, 10027, USA. matthew.romo@sph.cuny.edu.ORCID http://orcid.org/0000-0002-3038-0644
Marisela HernándezDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Osvaldo-Germán AstudilloAdministración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Dr. Carlos Malbrán", Buenos Aires, Argentina.
Gustavo DiegoAdministración Nacional de Laboratorios e Institutos de Salud (ANLIS) "Dr. Carlos Malbrán", Buenos Aires, Argentina.
Jorge Luis de-la-Rosa-AranaInstituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Secretaria de Salud, Mexico City, Mexico.
Antonio Meza-LucasInstituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Secretaria de Salud, Mexico City, Mexico.
Ricardo García-RodeaInstituto de Diagnóstico y Referencia Epidemiológicos (InDRE), Secretaria de Salud, Mexico City, Mexico.
Andrea ToledoUnidad de Neuroinflamación, Instituto de Investigaciones Biomédicas-Universidad Nacional Autónoma de México/Instituto Nacional de Neurología y Neurocirugía/Facultad de Medicina-Universidad Nacional Autónoma de México, Mexico City, Mexico.
R Michael E ParkhouseInstituto Gulbenkian de Ciência (IGC), 2780-156, Oeiras, Portugal.
Teresa GarateInstituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Edda SciuttoDepartamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Agnès FleuryUnidad de Neuroinflamación, Instituto de Investigaciones Biomédicas-Universidad Nacional Autónoma de México/Instituto Nacional de Neurología y Neurocirugía/Facultad de Medicina-Universidad Nacional Autónoma de México, Mexico City, Mexico. afleury@iibiomedicas.unam.mx.
Secretaria de Salud · MXAdministración Nacional de Laboratorios e Institutos de Salud · ARInstituto Nacional de Neurología y Neurocirugía · MXUniversidad Nacional Autónoma de México · MXInstituto de Salud Carlos III · ESInstituto Gulbenkian de Ciência · PTThe Graduate Center, CUNY · US

Funding

Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo, CYTED 211RT0432PROVACADI, Instituto de Investigaciones Biomédicas, UNAM, México NA
6 · The paper itself

Abstract

The enzyme-linked immunoelectrotransfer blot (EITB) assay to detect antibodies in serum is a complementary tool for the diagnosis of neurocysticercosis (NCC). Presence of at least one glycoprotein band corresponding to a Taenia solium (T. solium) antigen indicates a positive result; however, EITB assays have multiple glycoprotein bands, and previous work has suggested that band patterns may have additional diagnostic value. We included 58 participants with a definitive diagnosis of NCC who received care at the Instituto Nacional de Neurología y Neurocirugía in Mexico City. Three different EITB tests were applied to participants' serum samples (LDBio, France; US Centers for Disease Control and Prevention [CDC]; and Instituto de Diagnóstico y Referencia Epidemiológicos [InDRE]). There was substantial variability in specific glycoprotein band patterns among the three assays. However, in age- and sex-adjusted logistic regression models, the number of glycoprotein bands was positively associated with the presence of vesicular extraparenchymal cysts (InDRE adjusted odds ratio [aOR] 1.60 p < 0.001; CDC aOR 6.31 p < 0.001; LDBio aOR 2.45 p < 0.001) and negatively associated with the presence of calcified parenchymal cysts (InDRE aOR 0.63 p < 0.001; CDC aOR 0.25 p < 0.001; LDBio aOR 0.44 p < 0.001). In a sensitivity analysis also adjusting for cyst count, results were similar. In all three EITB serum antibody tests, the number of glycoprotein bands consistently predicted cyst stage and location, although magnitude of effect differed.

Indexed as

AnimalsAntibodies, HelminthAntigens, HelminthEnzyme-Linked Immunosorbent AssayFemaleFranceGlycoproteinsHelminth ProteinsHumansMaleMexicoNeurocysticercosisOdds RatioSensitivity and SpecificityTaenia soliumAntibodies, HelminthAntigens, HelminthGlycoproteinsHelminth ProteinsCysticercosisHelminthsImmunoassayImmunologic testsParasitic diseasesTaenia solium

Identifiers

PMID32591864
OpenAlexW3038073481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.